spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Ardian  

 HSMN NewsFeed - 31 May 2022
Abbott's FreeStyle Libre(R) 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 26 May 2021
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
Devices Drug Delivery Endocrinology Regulatory
 HSMN NewsFeed - 1 Feb 2021
New Scientific Publications Show Diadem's Blood-Based AlzoSure(R) Biomarker Test Can Predict Which Patients Will Progress to Alzheimer's Disease Years Before Symptoms Occur
Diagnostics Neurology
 HSMN NewsFeed - 21 Jan 2021
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
Devices Monitoring Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 12 Nov 2020
Medtronic Launches InPen(TM) with Real-Time Guardian(TM) Connect CGM Data -- the First Integrated Smart Insulin Pen for People with Diabetes on MDI
Devices Drug Delivery Endocrinology Product Launch
 HSMN NewsFeed - 6 May 2019
Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats
Devices Monitoring Cardiology Product Launch
 HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Jun 2018
Egalet Appoints Industry Veteran John Varian to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 12 Mar 2018
Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 15 Dec 2017
Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Oct 2017
Olympus Announces Continued Expansion of Its GI Endoscopic Device Line with ESD Innovations
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 15 Aug 2017
Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
Devices Monitoring
 HSMN NewsFeed - 21 Feb 2017
Bristol-Myers Squibb Appoints Three New Independent Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Oct 2016
Medtronic Announces Health Canada Licence of the MiniMed(TM) 630G System with New User-Friendly Insulin Pump Design and SmartGuard(TM) Technology
Devices Drug Delivery Endocrinology Regulatory
 HSMN NewsFeed - 19 Sep 2016
Egalet Appoints Patrick Shea as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2016
Egalet Settles Patent Litigations with Purdue Pharma
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 Feb 2016
Egalet Announces FDA Acceptance of New Drug Application for ARYMO(TM) ER (Morphine Sulfate) Extended-Release Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 8 Feb 2016
Angel Medical Systems Announces FDA Advisory Committee Meeting for Review of the AngelMed Guardian(R) System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Jan 2016
United-Guardian Receives FDA Approval to Market New Single-Dose Form of Renacidin(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2015
Egalet Appoints Mark Strobeck, Ph.D. to Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2014
Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jun 2014
Solace Therapeutics Receives Two FDA Clearances towards Providing Women an Office-Based Treatment for Stress Urinary Incontinence (SUI).
Devices Urology FDA
 HSMN NewsFeed - 1 May 2014
Lightstone Ventures Closes First Fund at $172 Million
Venture Capital
 HSMN NewsFeed - 9 Jan 2014
Covidien, Lightstone Ventures, New Enterprise Associates Announce Series A Investment in FIRE1
Devices Venture Capital Personnel
 HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Oct 2013
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
Devices Drug Delivery Monitoring Endocrinology FDA
 HSMN NewsFeed - 9 Oct 2013
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
Devices Monitoring Cardiology Regulatory
 HSMN NewsFeed - 17 Dec 2012
Angel Medical Systems, Inc. Completes Initial Closing of $27.5 Million Financing
Devices Cardiology Monitoring Venture Capital Personnel
 HSMN NewsFeed - 17 Oct 2012
SV Life Sciences and Third Rock Ventures Launch Transformative Medical Device Company Cibiem with $10 Million Series A
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 21 Aug 2012
FDA Clears Wireless ViSi(R) Mobile Patient Monitoring System Aimed at Enhancing Patient Safety for Ambulatory Hospital Patients
Devices Monitoring FDA
 HSMN NewsFeed - 24 Jul 2012
Histogenics Closes $49 Million Series A Fundraising to Support Commercial Development of Transformational Cartilage Repair Products
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 18 Oct 2011
EBR Systems, Inc. Appoints Allan Will President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 25 Jul 2011
Baxter Announces FDA Approval of Subcutaneous Route of Administration for GAMMAGARD LIQUID for Patients with Primary Immunodeficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jan 2011
Vascular Solutions Acquires Zerusa Limited and the Guardian(R) Hemostasis Valves
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2011
Medtronic Completes Acquisition of Ardian
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2010
Medtronic Signs Agreement to Acquire Ardian
Devices Mergers & Acquisitions
 HSMN NewsFeed - 22 Sep 2010
Angel Medical Systems Receives CE Mark Approval for the AngelMed Guardian, an Implantable Device Designed to Provide Early Warning of a Heart Attack
Devices Cardiology Regulatory
 HSMN NewsFeed - 21 Jun 2010
Ardian(R) Demonstrates 2-Year Durability of Blood Pressure Reduction in Hypertension Patients Treated with Symplicity(R) Catheter System(TM)
Devices Cardiology
 HSMN NewsFeed - 4 Jun 2010
Ascenta Therapeutics Licenses Cancer Drug Candidates to sanofi-aventis
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 3 Jun 2010
Ardian(R) Receives 2010 EuroPCR Innovation Award and Demonstrates Further Durability of Renal Denervation Treatment for Hypertension
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2009
Vascular Solutions and Zerusa Limited Announce FDA Market Clearance for the Next Generation Guardian II Hemostasis Valve
Devices FDA
 HSMN NewsFeed - 25 Sep 2009
Ardian(R) Demonstrates Durable Blood Pressure Reduction in Hypertension Patients Treated with Symplicity(R) Catheter System(TM)
Devices Cardiology
 HSMN NewsFeed - 9 Sep 2009
St. Jude Medical Receives CE Mark Approval for World's Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson's Disease
Devices Neurology Regulatory
 HSMN NewsFeed - 23 Mar 2009
Ardian Completes $47 Million Financing Led by Medtronic to Develop Hypertension Treatment
Devices Cardiology Venture Capital
 HSMN NewsFeed - 9 Jan 2009
Merck & Co., Inc. Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 through 45
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Nov 2008
GARDASIL®, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jun 2008
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
Biopharmaceuticals Oncology FDA Regulatory
 HSMN NewsFeed - 25 Jun 2008
Merck & Co., Inc Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 through 45
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jun 2008
NanoGuardian Client Receives FDA Approval for Its Nanoencryption Technology
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Mar 2008
Supplemental Application for GARDASIL(R), Merck's Cervical Cancer Vaccine, Designated Priority Review by the U.S. FDA for Use in Women 27 through 45
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2007
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Nov 2007
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Nov 2007
Introgen Therapeutics Highlights Summary ADVEXIN Data at the Third International Workshop on Mutant p53 and the Symposium on Li-Fraumeni Syndrome
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Nov 2007
Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Sep 2007
Merck to Donate Three Million Doses of Gardasil(R), its Cervical Cancer Vaccine, to Support Vaccination Programs in Lowest Income Nations
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Aug 2007
Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2007
FDA Classifies Baxter's Field Corrective Action as a Class I Recall on Recently Manufactured or Upgraded Colleague Triple Channel Infusion Pumps (Models 2M8153, 2M8163 and 2M9163)
Devices Product Recall
 HSMN NewsFeed - 9 Jul 2007
Zerusa Limited and Vascular Solutions Announce U.S. Distribution of Guardian Hemostasis Valve
Devices Interventional Distribution
 HSMN NewsFeed - 22 Jun 2007
Medtronic Unveils New Advanced Diabetes Therapy Management Software at 67th Annual American Diabetes Association Meeting
Devices Endocrinology
 HSMN NewsFeed - 20 Jun 2007
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 May 2007
Data Published in The Lancet Show GARDASIL(R) was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
Biopharmaceuticals
 HSMN NewsFeed - 9 May 2007
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Apr 2007
Confirma, Inc. and Guardian Techologies International, Inc. Sign Collaboration and Strategic Alliance Agreement
Devices Radiology
 HSMN NewsFeed - 17 Apr 2007
Merck Submits New Cross-Protection Data for GARDASIL(R) to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Apr 2007
Signature Mapping(TM) CAD Technology to Enhance the Performance of Breast Cancer Detection
Devices Oncology Radiology
 HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2007
Medtronic Launches New Guardian(R) REAL-Time System with Miniature Transmitter and CareLink(TM) Personal Software
Devices Endocrinology
 HSMN NewsFeed - 12 Mar 2007
FDA Approves New Medtronic Continuous Glucose Monitoring Devices for Children and Teenagers
Devices FDA Endocrinology
 HSMN NewsFeed - 13 Nov 2006
Merck Launches National Advertising Campaign for GARDASIL(R), Merck's New Cervical Cancer Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2006
Merck's Cervical Cancer Vaccine, GARDASIL(R), Added to the CDC Vaccines for Children Contract
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Sep 2006
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Jul 2006
Medtronic Receives FDA Approval for Guardian(R) REAL-Time Continuous Glucose Monitoring System
Devices Endocrinology FDA
 HSMN NewsFeed - 29 Jun 2006
Merck's New Cervical Cancer Vaccine, GARDASIL(R), Unanimously Recommended by CDC Advisory Panel for Vaccination of Girls and Women 11 to 26 Years
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 May 2006
Gendux AB and Introgen Therapeutics File European Orphan Drug Designation for ADVEXIN
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 May 2006
Introgen's ADVEXIN p53 Therapy Provided to Cancer Patients With Li-Fraumeni Syndrome
Biopharmaceuticals Oncology FDA
Return to NewsFeed  

 Additional items found! 14

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 14 additional stories matching:
Ardian
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.